CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, cilt.64, sa.3, ss.167-175, 2003 (SCI İndekslerine Giren Dergi)
Background: Although angiotensin-converting enzyme inhibitors (ACEIs) have been shown to prolong life in patients with congestive heart failure (CHF), the prognosis of these patients remains poor.